Rein Therapeutics Inc. (RNTX) Options Greeks

Options Greeks measure sensitivity to various factors: Delta (price), Gamma (delta change), Theta (time decay), and Vega (volatility). They are essential for risk management and position sizing.

Rein Therapeutics Inc. (RNTX) operates in the Healthcare sector, specifically the Medical - Pharmaceuticals industry, with a market capitalization near $29.6M, listed on NASDAQ, employing roughly 11 people, carrying a beta of 1.42 to the broader market. Rein Therapeutics, Inc. Led by James Brian Windsor, public since 2017-06-29.

Options Greeks analysis provides sensitivity measures for price, time, and volatility. No recent options activity for RNTX as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how options Greeks is reported and how to read the data →